INTEST (INTT) SEC Filings

Steven J. Abrams reported disposition transactions in this Form 4 filing. InTest Corp (INTT) director Steven J. Abrams transferred 3,000 shares of common stock to a family trust on October 5, 2026, for no consideration. Abrams remains the beneficial owner of shares held by the trust. After the transfer, reported holdings include 3,000 shares held directly and 105,000 shares held indirectly through Steven J. Abrams Revocable Trust.

InTest Corporation (INTT) expects record third-quarter 2026 orders of $48 million to $50 million, an increase of 28% to 33% compared with the third quarter of 2025, and an estimated book-to-bill ratio above 1.3x. Revenue is expected at the high end of the company’s $33 million to $35 million guidance range, representing growth of more than 30% compared with $26.2 million in the third quarter of 2025. Backlog is expected to be $58 million to $60 million as of September 30, 2026, up approximately 28% to 32% from $45.4 million as of June 30, 2026.

These selected results are preliminary and subject to completion of financial closing procedures; actual results may vary materially. InTest defines orders as written customer requests for products or services and backlog as firm purchase orders for which revenue has not yet been recognized; contracts may include customer cancellation, termination or suspension provisions. Management said record back-end semiconductor orders led Q3 order activity and expects full-year 2026 revenue at the high end of its guidance range. InTest plans to report Q3 results on November 6, 2026.

InTest Corporation reported that it has further amended its existing senior credit facility with M&T Bank by entering into an Eighth Amendment to the Amended and Restated Loan and Security Agreement on August 14, 2026. This amendment extends the period during which InTest may request advances under its term loan facility until August 28, 2028, effectively lengthening the time the company can draw on this borrowing capacity. The Amended Credit Agreement continues to cover InTest and several subsidiaries, including Ambrell Corporation, inTEST EMS, LLC, Temptronic Corporation, Videology Imaging Corporation, Acculogic Ltd., Acculogic Inc., and Alfamation US, Inc., and is attached as an exhibit for reference.

InTest Corporation reported stronger results for the quarter and six months ended June 30, 2026. Quarterly revenue was $35.3 million, up from $28.1 million a year earlier, and six‑month revenue was $69.2 million versus $54.8 million. The company generated net earnings of $0.5 million for the quarter and $0.7 million for the first half, compared with losses in the prior‑year periods, driven by higher sales and improved operating income.

Cash and cash equivalents increased to $22.1 million from $14.2 million at year‑end, while operating cash flow for the first half was $3.0 million compared with $4.8 million last year. Total debt declined, with current and long‑term portions totaling $6.2 million versus $7.5 million at December 31, 2025. Total assets were $149.1 million and stockholders’ equity rose to $107.7 million. The company remains diversified across Semi and other markets, with notable growth in Auto/EV and continued customer concentration, as one customer represented 24% of quarterly revenue. Management also revised prior March 31, 2026 interim statements for an inventory and cost‑of‑revenue error related to a new ERP system, concluding the impacts were not material individually but required revision to avoid materially affecting current‑period results.

InTest Corporation reported second-quarter 2026 revenue of $35.3 million, up 25.5% year-over-year and its third straight quarter of sequential growth. Growth was driven largely by Auto/EV, which represented 38.1% of revenue, while non-semiconductor markets in total contributed approximately 74% of revenue.

GAAP net earnings were $0.5 million, or $0.04 per diluted share, compared with a loss of $0.5 million a year ago. Adjusted EPS was $0.09 versus $0.03, and Adjusted EBITDA rose to $2.2 million, up 73.7% year-over-year, though Adjusted EBITDA margin was 6.2%. Gross margin declined to 40.5% from 43.3% in the first quarter, reflecting a shift toward higher-volume, lower-margin Auto/EV products.

Orders in the quarter were $28.9 million, up 4.0% year-over-year but down 9.2% sequentially, while backlog was $45.4 million, up 19.8% year-over-year and down 12.4% sequentially. Cash and cash equivalents increased to $22.1 million, aided by $6.3 million provided by operating activities and a $1.0 million term-debt reduction. Management reiterated its raised full-year 2026 revenue outlook of $135–$140 million and expects third-quarter 2026 revenue of $33–$35 million with gross margin of about 44%.

Askeladden Capital Management LLC and Samir Patel report that they no longer beneficially own any shares of inTEST Corp common stock. The amendment lists 0 shares beneficially owned and 0.0% of the class, with no sole or shared voting or dispositive power.

The filing explains that securities were previously held in separately managed accounts for Askeladden’s investment advisory clients, but each reporting person now reports ownership of 5 percent or less of inTEST Corp’s common stock. Shares outstanding were 12,564,657 as of April 30, 2026; this is a baseline figure, not the amount involved in this amendment.

Vanguard Capital Management filed an amended Schedule 13G reporting its beneficial ownership in inTEST Corp common stock. Vanguard reports beneficial ownership of 589,953 shares, representing 4.69% of the class. It has sole voting power over 79,848 shares and sole dispositive power over all 589,953 shares, with no shared voting or dispositive power.

The holdings reflect securities beneficially owned or deemed to be beneficially owned by Vanguard Capital Management LLC together with certain affiliates and business divisions, including investment companies and managed accounts over which they exercise voting and/or dispositive power. No other individual person's interest in these securities exceeds 5% of the class.

InTest Corporation reported preliminary results for the quarter ended June 30, 2026 and updated its 2026 outlook. For the second quarter, revenue is expected to be approximately $35 million, gross margin approximately 40%, and operating expenses about $13.9 million, compared with prior guidance of $32 million to $34 million in revenue, around 45% gross margin, and $13.8 million to $14.2 million in operating expenses.

The company identified implementation issues with a new ERP system at its Alfamation business that led to overstated inventory and gross margin in the first quarter of 2026. Management determined that first quarter consolidated gross profit was overstated by about $750,000, requiring a 220-basis-point downward revision to previously reported Q1 gross margin. InTest plans to revise first quarter financial results and expects to report a material weakness in internal control over financial reporting, although it believes this weakness has been remediated.

For full year 2026, InTest now expects revenue of $135 million to $140 million, up from prior guidance of $130 million to $135 million, and a full year gross margin of approximately 43% versus prior guidance of 45%. Full year operating expenses are still projected at $55 million to $57 million, with an expected effective tax rate of about 18%.

BlackRock, Inc. reports a passive ownership stake in INTEST CORP common stock on a Schedule 13G. BlackRock states that it beneficially owns 824,291 shares, representing 6.6% of the outstanding common stock.

BlackRock reports sole voting power814,108 shares and sole dispositive power824,291 shares, with no shared voting or dispositive power. Various underlying clients may receive dividends or sale proceeds, but no single client holds more than five percent of INTEST CORP’s total outstanding shares.